Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Histochem Cell Biol. 2014 Jul 8;142(6):713–720. doi: 10.1007/s00418-014-1245-7

Figure 3. Activation of DNA repair pathways in human pancreatic cancer.

Figure 3

(A) Immunostaining of RAD51 and KU70 of duct was performed from normal (C1-C3) and tumor (T1, T2, and T4) pancreatic tissues. Representative images from C2 and T1 are shown. (B) Immunostaining of RAD51 and KU70 of pancreatic body was performed from normal (C1-C3) and tumor (T1-T4) pancreatic tissues. Representative images from C2 and T3 are shown. Enlarged box denotes RAD51 foci. Scale bar: 20 µm. (C) Numbers of positive Rad51 and Ku70 cells around the duct in normal pancreas (C1-C3) and pancreatic tumor (T1, T2, and T4) were counted. Three independent experiments were averaged. The error bars represent the SD.